PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

Post-LOE

amitriptyline hydrochloride; perphenazine

PharmaIN

ANDAORALTABLET

Approved

Nov 1986

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (amitriptyline hydrochloride; perphenazine) by PharmaIN is clinical pharmacology amitriptyline hydrochloride is an antidepressant with sedative effects. Approved for depression. First approved in 1986.

Drug data last refreshed 18h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Amitriptyline hydrochloride is an antidepressant with sedative effects. Its mechanism of action in man is not known. It is not a monoamine oxidase inhibitor and it does not act primarily by stimulation of the central nervous system. Amitriptyline inhibits the membrane pump…

Indications (1)

depression

Company

Worked on PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.